The management for this case included full labs, including a metabolic panel to assess for electrolyte abnormalities, liver function tests to assess for possible hepatic and biliary involvement, lipase to stratify risk for pancreatitis, creatine kinase to assess for potential rhabdomyolysis, urine studies, infusion of potassium chloride, analgesia and symptom control including antiemetics, and careful consideration of intravenous fluids given her hypokalemia, which represents a risk factor for over-correction of sodium and risk for osmotic demyelination
Table of Contents The Three Receptors Targeted by Retatrutide How Each Receptor Contributes to Weight Loss and Metabolism Retatrutide Compared to Other Multi-Receptor Agonists Clinical Evidence and Trial Findings from Current Research Potential Side Effects Linked to Receptor Activity What UK Patients Should Know About Retatrutide's Development Frequently Asked Questions The Three Receptors Targeted by Retatrutide Retatrutide targets three receptors: GLP-1R, GIPR, and GCGR
Urgent NAION Symptoms Sudden, painless vision loss in one eye (often noticed upon waking up) Trouble seeing colors clearly or washed-out colors Light sensitivity Blurry or dim vision A shadow or darkened area in your vision Missing areas in your vision (blind spots) To file an Ozempic blindness lawsuit, you will need to be diagnosed with NAION
After that, the dose increases to 0.5 mg weekly
This is where your tirzepatide should live
NNMT inhibition produces metabolic effects including increased NAD+ levels and reduced lipogenesis
